Stem Cell Therapy For Parkinson's Disease
Parkinson's Disease is caused by the degeneration of dopamine-producing cells in a certain part of the brain. By studying the embryonic development of the central nervous system, research groups led by Johan Ericson and Thomas Perlmann at Karolinska Institutet have been able to show that two genes, Lmx1a and Msx1, play a critical part in the formation of cerebral dopamine cells.
They also demonstrate how these findings can be used to control the formation of dopamine-producing cells from stem cells in a highly effective manner. This represents an important step in the development of a stem-cell based treatment for Parkinson's Disease.
Identification of intrinsic determinants of midbrain dopamine neurons
Andersson E, Marklund U, Deng Q, Friling S, Alekseenko Z, Robert B, Perlmann T, Ericson J.
Cell 27 January 2006
Press Officer Katarina Sternudd
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:
Lombardi, Yvonne. "Stem Cell Therapy For Parkinson's Disease." Medical News Today. MediLexicon, Intl., 27 Jan. 2006. Web.
24 Jun. 2017. <http://www.medicalnewstoday.com/releases/36666.php>
Lombardi, Y. (2006, January 27). "Stem Cell Therapy For Parkinson's Disease." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.